OUTSET MEDICAL INC (OM) Stock Overview
USA - NASDAQ:OM - US6901452069 - Common Stock
OM Key Statistics, Chart & Performance
The current stock price of OM is 12.39 USD. In the past month the price decreased by -9.06%. In the past year, price increased by 37.3%.
OM Latest News, Press Relases and Analysis
OM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.76 | 228.19B | ||
| ISRG | INTUITIVE SURGICAL INC | 54.1 | 156.13B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.51 | 140.53B | ||
| SYK | STRYKER CORP | 28.33 | 139.19B | ||
| MDT | MEDTRONIC PLC | 17.24 | 122.28B | ||
| BDX | BECTON DICKINSON AND CO | 13.11 | 53.61B | ||
| IDXX | IDEXX LABORATORIES INC | 52.47 | 50.41B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.17 | 42.51B | ||
| RMD | RESMED INC | 28.57 | 39.95B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.43 | 32.82B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.5 | 26.53B | ||
| DXCM | DEXCOM INC | 38.28 | 25.52B |
Related stock screener links
About OM
Company Profile
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 354 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Company Info
OUTSET MEDICAL INC
3052 Orchard Drive
San Jose CALIFORNIA 95134 US
CEO: Leslie Trigg
Employees: 354
Phone: 16692318200
OUTSET MEDICAL INC / OM FAQ
What is the stock price of OUTSET MEDICAL INC today?
The current stock price of OM is 12.39 USD. The price decreased by -0.48% in the last trading session.
What is the ticker symbol for OUTSET MEDICAL INC stock?
The exchange symbol of OUTSET MEDICAL INC is OM and it is listed on the Nasdaq exchange.
On which exchange is OM stock listed?
OM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OUTSET MEDICAL INC stock?
12 analysts have analysed OM and the average price target is 26.27 USD. This implies a price increase of 111.99% is expected in the next year compared to the current price of 12.39. Check the OUTSET MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OUTSET MEDICAL INC worth?
OUTSET MEDICAL INC (OM) has a market capitalization of 220.17M USD. This makes OM a Micro Cap stock.
How many employees does OUTSET MEDICAL INC have?
OUTSET MEDICAL INC (OM) currently has 354 employees.
What are the support and resistance levels for OUTSET MEDICAL INC (OM) stock?
OUTSET MEDICAL INC (OM) has a support level at 9.36 and a resistance level at 14.45. Check the full technical report for a detailed analysis of OM support and resistance levels.
Is OUTSET MEDICAL INC (OM) expected to grow?
The Revenue of OUTSET MEDICAL INC (OM) is expected to grow by 10.07% in the next year. Check the estimates tab for more information on the OM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OUTSET MEDICAL INC (OM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OM, evaluating the profitability, health, valuation and growth aspects
- OUTSET MEDICAL INC (OM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OUTSET MEDICAL INC (OM) Sales and EPS estimates to see what analysts future expectations are.
- OUTSET MEDICAL INC (OM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OUTSET MEDICAL INC (OM) Insider and Institutional Ownership to learn about the owners and their transactions.
- OUTSET MEDICAL INC (OM) Stock Chart to make your own analysis
- OUTSET MEDICAL INC (OM) Latest news and press-releases to stay up to date.
Does OUTSET MEDICAL INC (OM) stock pay dividends?
OM does not pay a dividend.
When does OUTSET MEDICAL INC (OM) report earnings?
OUTSET MEDICAL INC (OM) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of OUTSET MEDICAL INC (OM)?
OUTSET MEDICAL INC (OM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.48).
What is the Short Interest ratio of OUTSET MEDICAL INC (OM) stock?
The outstanding short interest for OUTSET MEDICAL INC (OM) is 11.26% of its float. Check the ownership tab for more information on the OM short interest.
OM Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to OM. When comparing the yearly performance of all stocks, OM turns out to be only a medium performer in the overall market: it outperformed 46.63% of all stocks.
OM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OM. Both the profitability and financial health of OM have multiple concerns.
OM Financial Highlights
Over the last trailing twelve months OM reported a non-GAAP Earnings per Share(EPS) of -15.48. The EPS increased by 55.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.9% | ||
| ROE | -63.25% | ||
| Debt/Equity | 0.61 |
OM Forecast & Estimates
12 analysts have analysed OM and the average price target is 26.27 USD. This implies a price increase of 111.99% is expected in the next year compared to the current price of 12.39.
For the next year, analysts expect an EPS growth of 83.58% and a revenue growth 10.07% for OM